Your thoughts about Pluvicto supply

[Darryl]

Hi, What are your thoughts about last week's update about Pluvicto supply? Please write these as a reply to this email, as I want to advocate for whatever issues you have, and I have an early Friday morning meeting to do so.

Here's last week's notice:

Novartis has received FDA approval to begin supplying Pluvicto for US commercial use from the Novartis Radioligand Therapy (RLT) manufacturing facility in Millburn, New Jersey. Production will begin in the coming weeks and gradually ramp up. The site is expected to contribute meaningfully to supply in the third quarter after the anticipated approval of additional lines at the site. Capacity should continue to increase through the second-half of this year, helping to ensure stable, reliable supply to patients. The RLT manufacturing facility in Ivrea, Italy, will continue to supply the US market. 

[Fightinghard]

daryl

Please disregard my comments in the poll. I had not seen the new update.

However i would have said “this type of progress update is exactly what the company should release on a regular schedule, until the supply chain pipeline is running smoothly again. Doing so would help improve the public perception of the Company, while stopping thoughts that something mysterious, or even nefarious, could be happening behind the scenes”

Too little and too late right now, but with more frequent updates moving forward, perceptions can improve.

[kwyq]

I contacted University Heidelberg, applying for the Lu177+Ac225 treatment for my father yesterday. However, I was declined due to limited capacity. Only regional patients are admitted for treatment there, therefore appointments for patients abroad are not available. It seems that Pluvicto supply is still a problem.